Abcam Plc (LON:ABC) had its price target increased by J P Morgan Chase & Co from GBX 864 ($11.65) to GBX 946 ($12.75) in a research note released on Monday morning. J P Morgan Chase & Co currently has a neutral rating on the stock.

A number of other brokerages have also recently weighed in on ABC. Berenberg Bank started coverage on shares of Abcam Plc in a report on Tuesday, June 27th. They issued a buy rating and a GBX 1,100 ($14.83) price objective for the company. Peel Hunt restated a hold rating and issued a GBX 750 ($10.11) price objective on shares of Abcam Plc in a report on Monday, September 11th. Panmure Gordon restated a sell rating on shares of Abcam Plc in a report on Thursday, July 27th. Finally, Numis Securities Ltd restated an add rating and issued a GBX 1,116 ($15.05) price objective on shares of Abcam Plc in a report on Thursday, July 27th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the stock. Abcam Plc currently has an average rating of Hold and a consensus target price of GBX 927.67 ($12.51).

Abcam Plc (LON ABC) opened at 1028.00 on Monday. The stock has a 50 day moving average price of GBX 1,057.28 and a 200 day moving average price of GBX 958.01. Abcam Plc has a 52 week low of GBX 759.50 and a 52 week high of GBX 1,113.00. The company’s market cap is GBX 2.08 billion.

ILLEGAL ACTIVITY WARNING: “Abcam Plc (ABC) Price Target Increased to GBX 946 by Analysts at J P Morgan Chase & Co” was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at

In other Abcam Plc news, insider Louise Patten acquired 1,636 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The stock was purchased at an average price of GBX 1,079 ($14.55) per share, for a total transaction of £17,652.44 ($23,799.97).

Abcam Plc Company Profile

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Analyst Recommendations for Abcam Plc (LON:ABC)

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.